BioCentury
ARTICLE | Top Story

Laughren retires

December 8, 2012 1:35 AM UTC

Thomas Laughren, the director of FDA's Division of Psychiatry Products, retired on Dec. 1. The agency said Deputy Director Mitchell Mathis is serving as acting director, but did not disclose plans for...